Resonance Health Ltd has released a press release.
New Work Order to provide services for Clinical Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Resonance Health
- Pause in Trading
- Change of Substantial Shareholder Notification
- Additional Information on Announcement Dated 23 August 2018
- Resonance Health contracted for two new clinical trials
- TGA, CE Mark clearance for A.I. Solution FerriSmart
Later from Resonance Health
- Change of Director's Interest Notice
- R&D Tax Incentive
- FDA Clearance Granted for FerriSmart
- Response to ASX Price and Volume Query
- Execution of License Agreement
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health